Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine Tumors
Clinical trial NCT02063958 · COMPLETED
Trial details
- NCT number
- NCT02063958
- Sponsor
- Esanex Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2017-03-27
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.